Skip to content
← Ovarian Germ Cell Tumors

HEALTH PROFESSIONAL · SOURCE READING

Dysgerminomas

Source: Ovarian Germ Cell Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: September 18, 2024 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Stage IV Ovarian Germ Cell Tumors

Treatment options for patients with stage IV dysgerminomas include:

Total abdominal hysterectomy and bilateral salpingo-oophorectomy with adjuvant chemotherapy.

Unilateral salpingo-oophorectomy with adjuvant chemotherapy.

Clinical trials.

For patients with stage IV dysgerminoma, total abdominal hysterectomy and bilateral salpingo-oophorectomy is recommended with removal of as much gross tumor in the abdomen and pelvis as can be done safely without resection of portions of the urinary tract or large segments of small or large bowel, although unilateral salpingo-oophorectomy should be considered in patients who wish to preserve fertility.[1,2] Chemotherapy with bleomycin, etoposide, and cisplatin (BEP) can cure the majority of such patients. Stage IV dysgerminoma is not treated with radiation therapy, but rather with chemotherapy, preferably with three to four courses of cisplatin-containing combination chemotherapy such as BEP.[1] A second-look operation following treatment is rarely beneficial.

Source links and citations

Publication references

Read the original reference and check its publication notices.

Preserved source evidence · Not medical advice